C000203168 Holdings — EQ/T. Rowe Price Health Sciences Portfolio
All 176 reported holdings of EQ/T. Rowe Price Health Sciences Portfolio (C000203168) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 10.20% | $16.21M |
| Thermo Fisher Scientific, Inc. | 4.13% | $6.56M |
| Intuitive Surgical, Inc. | 3.71% | $5.90M |
| Stryker Corp. | 3.53% | $5.62M |
| Merck & Co., Inc. | 3.48% | $5.53M |
| AstraZeneca plc | 3.21% | $5.10M |
| UnitedHealth Group, Inc. | 3.11% | $4.95M |
| Argenx SE | 3.04% | $4.83M |
| AbbVie, Inc. | 2.91% | $4.63M |
| Regeneron Pharmaceuticals, Inc. | 2.71% | $4.31M |
| Gilead Sciences, Inc. | 2.67% | $4.24M |
| Johnson & Johnson | 2.48% | $3.94M |
| Vertex Pharmaceuticals, Inc. | 2.47% | $3.93M |
| Danaher Corp. | 2.08% | $3.31M |
| Alnylam Pharmaceuticals, Inc. | 1.69% | $2.68M |
| Ascendis Pharma A/S | 1.46% | $2.32M |
| Revolution Medicines, Inc. | 1.40% | $2.22M |
| United Therapeutics Corp. | 1.36% | $2.17M |
| BeOne Medicines Ltd. | 1.25% | $1.98M |
| Roivant Sciences Ltd. | 1.17% | $1.86M |
| Protagonist Therapeutics, Inc. | 1.16% | $1.84M |
| Insmed, Inc. | 1.09% | $1.74M |
| Summit Therapeutics, Inc. | 1.08% | $1.72M |
| Natera, Inc. | 1.07% | $1.70M |
| Tenet Healthcare Corp. | 1.06% | $1.68M |
| Amgen, Inc. | 1.02% | $1.62M |
| BrightSpring Health Services, Inc. | 1.01% | $1.61M |
| Boston Scientific Corp. | 0.96% | $1.53M |
| HCA Healthcare, Inc. | 0.95% | $1.51M |
| Invesco Govt And Agcy Lex | 0.95% | $1.50M |
| Guardant Health, Inc. | 0.92% | $1.47M |
| CVS Health Corp. | 0.89% | $1.42M |
| Kymera Therapeutics, Inc. | 0.82% | $1.30M |
| Cigna Group (The) | 0.78% | $1.24M |
| CG oncology, Inc. | 0.74% | $1.18M |
| Cardinal Health, Inc. | 0.73% | $1.16M |
| Krystal Biotech, Inc. | 0.70% | $1.12M |
| Elevance Health, Inc. | 0.70% | $1.10M |
| Scholar Rock Holding Corp. | 0.66% | $1.04M |
| Ionis Pharmaceuticals, Inc. | 0.64% | $1.02M |
| Bridgebio Pharma, Inc. | 0.63% | $1.01M |
| Structure Therapeutics, Inc. | 0.61% | $967.28K |
| Chugai Pharmaceutical Co. Ltd. | 0.60% | $951.65K |
| Celcuity, Inc. | 0.59% | $932.52K |
| Praxis Precision Medicines, Inc. | 0.58% | $928.55K |
| Royalty Pharma plc | 0.58% | $924.53K |
| Centessa Pharmaceuticals plc | 0.56% | $897.91K |
| Cencora, Inc. | 0.55% | $880.53K |
| Vera Therapeutics, Inc. | 0.49% | $772.50K |
| Apogee Therapeutics, Inc. | 0.47% | $743.73K |
| Nuvalent, Inc. | 0.46% | $730.67K |
| Abivax SA | 0.45% | $721.88K |
| Edwards Lifesciences Corp. | 0.44% | $703.58K |
| Spyre Therapeutics, Inc. | 0.44% | $699.05K |
| Incyte Corp. | 0.43% | $678.32K |
| Dianthus Therapeutics, Inc. | 0.42% | $674.38K |
| Cytokinetics, Inc. | 0.42% | $674.06K |
| Crinetics Pharmaceuticals, Inc. | 0.41% | $644.35K |
| Madrigal Pharmaceuticals, Inc. | 0.39% | $627.12K |
| Immunome, Inc. | 0.36% | $570.81K |
| IQVIA Holdings, Inc. | 0.36% | $567.90K |
| Kodiak Sciences, Inc. | 0.35% | $557.20K |
| Belite Bio, Inc. | 0.33% | $526.15K |
| Monte Rosa Therapeutics, Inc. | 0.32% | $510.20K |
| Mirum Pharmaceuticals, Inc. | 0.30% | $482.32K |
| Terns Pharmaceuticals, Inc. | 0.30% | $470.37K |
| Moderna, Inc. | 0.28% | $444.65K |
| Axsome Therapeutics, Inc. | 0.27% | $435.90K |
| Alignment Healthcare, Inc. | 0.27% | $430.91K |
| Oruka Therapeutics, Inc. | 0.26% | $416.04K |
| Revvity, Inc. | 0.26% | $414.13K |
| Beam Therapeutics, Inc. | 0.26% | $411.64K |
| Alumis, Inc. | 0.26% | $410.31K |
| West Pharmaceutical Services, Inc. | 0.25% | $401.02K |
| Sonova Holding AG | 0.25% | $389.65K |
| Sionna Therapeutics, Inc. | 0.24% | $383.06K |
| IDEXX Laboratories, Inc. | 0.24% | $375.90K |
| MBX Biosciences, Inc. | 0.23% | $372.08K |
| Rhythm Pharmaceuticals, Inc. | 0.23% | $369.88K |
| McKesson Corp. | 0.23% | $359.99K |
| ORIC Pharmaceuticals, Inc. | 0.23% | $357.61K |
| Immunocore Holdings plc | 0.22% | $347.54K |
| Rapport Therapeutics, Inc. | 0.22% | $346.04K |
| Caris Life Sciences, Inc. | 0.21% | $337.02K |
| Nurix Therapeutics, Inc. | 0.21% | $330.52K |
| Arrowhead Pharmaceuticals, Inc. | 0.21% | $329.86K |
| Erasca, Inc. | 0.21% | $328.45K |
| Billiontoone, Inc. | 0.20% | $320.34K |
| Vaxcyte, Inc. | 0.20% | $311.00K |
| Bio-Rad Laboratories, Inc. | 0.19% | $308.58K |
| MoonLake Immunotherapeutics | 0.19% | $304.78K |
| Novo Nordisk A/S | 0.19% | $296.02K |
| Palvella Therapeutics, Inc. | 0.19% | $296.04K |
| Centene Corp. | 0.18% | $286.64K |
| Celldex Therapeutics, Inc. | 0.17% | $273.17K |
| Encompass Health Corp. | 0.17% | $271.33K |
| Stoke Therapeutics, Inc. | 0.17% | $269.99K |
| Relay Therapeutics, Inc. | 0.16% | $254.04K |
| Bicara Therapeutics, Inc. | 0.16% | $252.23K |
| BeOne Medicines Ltd. | 0.16% | $249.16K |
| Repligen Corp. | 0.16% | $247.42K |
| WaVe Life Sciences Ltd. | 0.15% | $242.82K |
| Kestra Medical Technologies Ltd. | 0.15% | $241.63K |
| Charles River Laboratories International, Inc. | 0.15% | $241.50K |
| Tarsus Pharmaceuticals, Inc. | 0.15% | $237.67K |
| Disc Medicine, Inc. | 0.14% | $228.20K |
| Allogene Therapeutics, Inc. | 0.14% | $225.17K |
| Cogent Biosciences, Inc. | 0.14% | $219.85K |
| Tango Therapeutics, Inc. | 0.13% | $209.20K |
| Replimune Group, Inc. | 0.13% | $207.66K |
| Molina Healthcare, Inc. | 0.13% | $201.68K |
| Sartorius AG | 0.13% | $200.59K |
| Kyverna Therapeutics, Inc. | 0.12% | $198.15K |
| Viatris, Inc. | 0.12% | $197.25K |
| Pharvaris NV | 0.12% | $196.96K |
| Ocular Therapeutix, Inc. | 0.12% | $190.57K |
| Climb Bio, Inc. | 0.12% | $190.43K |
| Ideaya Biosciences, Inc. | 0.12% | $187.62K |
| Tyra Biosciences, Inc. | 0.12% | $183.84K |
| Biohaven Ltd. | 0.12% | $183.53K |
| Corvus Pharmaceuticals, Inc. | 0.11% | $180.78K |
| Olema Pharmaceuticals, Inc. | 0.11% | $177.43K |
| Shattuck Labs, Inc. | 0.11% | $171.68K |
| Medpace Holdings, Inc. | 0.11% | $168.07K |
| Denali Therapeutics, Inc. | 0.11% | $167.00K |
| Iovance Biotherapeutics, Inc. | 0.10% | $159.67K |
| Generate Biomedicines, Inc. | 0.10% | $158.75K |
| Cullinan Therapeutics, Inc. | 0.10% | $153.47K |
| PROCEPT BioRobotics Corp. | 0.09% | $150.86K |
| Liquidia Corp. | 0.09% | $148.62K |
| Lantheus Holdings, Inc. | 0.09% | $144.12K |
| Atrium Therapeutics, Inc. | 0.09% | $139.05K |
| Viridian Therapeutics, Inc. | 0.08% | $124.77K |
| Entrada Therapeutics, Inc. | 0.07% | $118.19K |
| Xencor, Inc. | 0.07% | $113.00K |
| SpyGlass Pharma, Inc. | 0.07% | $109.18K |
| Sensorion SA | 0.07% | $108.53K |
| Zai Lab Ltd. | 0.06% | $102.97K |
| Agios Pharmaceuticals, Inc. | 0.06% | $101.19K |
| Immatics NV | 0.06% | $99.38K |
| Inspire Medical Systems, Inc. | 0.06% | $98.00K |
| Bicycle Therapeutics plc | 0.06% | $96.60K |
| Alto Neuroscience, Inc. | 0.06% | $92.17K |
| Evommune, Inc. | 0.06% | $92.14K |
| Aktis Oncology, Inc. | 0.05% | $87.02K |
| Crescent Biopharma, Inc. | 0.05% | $81.09K |
| Immuneering Corp. | 0.04% | $66.86K |
| Rocket Pharmaceuticals, Inc. | 0.04% | $60.70K |
| Annexon, Inc. | 0.04% | $58.91K |
| BridgeBio Oncology Therapeutics, Inc. | 0.04% | $58.89K |
| Tectonic Therapeutic, Inc. | 0.04% | $58.73K |
| Eikon Therapeutics, Inc. | 0.03% | $53.65K |
| Aura Biosciences, Inc. | 0.03% | $48.82K |
| Immix Biopharma, Inc. | 0.03% | $45.55K |
| Hims & Hers Health, Inc. | 0.02% | $35.29K |
| Saluda Medical, Inc. | 0.02% | $32.95K |
| Immunovant, Inc. | 0.02% | $32.29K |
| Monopar Therapeutics, Inc. | 0.02% | $31.29K |
| Enliven Therapeutics, Inc. | 0.02% | $31.36K |
| RadNet, Inc. | 0.01% | $23.64K |
| Adlai Nortye Ltd. | 0.01% | $23.31K |
| LENZ Therapeutics, Inc. | 0.01% | $23.37K |
| Beta Bionics, Inc. | 0.01% | $18.25K |
| Nuvation Bio, Inc. | 0.01% | $16.53K |
| Janux Therapeutics, Inc. | 0.01% | $15.60K |
| MediWound Ltd. | 0.01% | $15.24K |
| Tenax Therapeutics, Inc. | 0.01% | $13.46K |
| Japanese Yen | 0.01% | $13.18K |
| Ginkgo Bioworks Holdings, Inc. | 0.01% | $8.25K |
| Cabaletta Bio, Inc. | 0.00% | $2.84K |
| Generation Bio Co. | 0.00% | $2.37K |
| Euro | 0.00% | $434 |
| Danish Krone | 0.00% | $341 |
| Swiss Franc | 0.00% | $248 |
| Swedish Krona | 0.00% | $0 |
| Hong Kong Dollar | 0.00% | $0 |
C000203168 overview: performance, fees, allocation and SEC filings